FDA.reportPublic FDA data

Lithobid 300 MG Extended Release Oral Tablet

RxCUI
206786
RxNorm name
Lithobid 300 MG Extended Release Oral Tablet
Display name
Lithobid 300 MG Extended Release Oral Tablet
Full name
Lithobid 300 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LITHOBIDLITHIUM CARBONATEANI Pharmaceuticals, Inc.f7f5b69a-c2a1-4586-a189-1475d41387c02026-08-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 206786

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f7f5b69a-c2a1-4586-a189-1475d41387c0LITHOBID 300 MG Extended Release Oral Tablet [PSN] · lithium carbonate 300 MG Extended Release Oral Tablet [Lithobid] [SBD] · LiCO3 300 MG Extended Release Oral Tablet [Lithobid] [SY] · Lithobid 300 MG Extended Release Oral Tablet [SY]412LITHOBID ® (Lithium Carbonate USP) Extended-Release Tablets 300 mg20221028